Latest Insider Transactions at Greenwich Life Sciences, Inc. (GLSI)
This section provides a real-time view of insider transactions for Greenwich Life Sciences, Inc. (GLSI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Greenwich LifeSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Greenwich LifeSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2020
|
Kenneth Hallock Director |
BUY
Open market or private purchase
|
Indirect |
8,333
+2.07%
|
$33,332
$4.6 P/Share
|
|
Sep 29
2020
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
16,667
+1.39%
|
$66,668
$4.6 P/Share
|
|
Sep 29
2020
|
David Mc Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
171,622
+5.84%
|
-
|
|
Sep 29
2020
|
Kenneth Hallock Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
116,575
+9.77%
|
-
|
|
Sep 29
2020
|
Snehal Patel CEO and CFO |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,360,635
+21.9%
|
-
|
|
Sep 29
2020
|
Snehal Patel CEO and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
304,489
+6.23%
|
-
|